Drug intelligence / Profile preview

Mecobe

Development stage
Unknown
Lead developer
Myralis
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral, Sublingual
01

Overview

Mecobe is a vitamin B12 dietary supplement developed and manufactured by Myralis Indústria Farmacêutica Ltda. Its active ingredient is methylcobalamin (mecobalamina), a bioactive form of vitamin B12, provided at a dose of 1,000 mcg per sublingual tablet. Mecobe is indicated for the treatment of vitamin B12 deficiency, particularly in patients using metformin, and for general supplementation, including the management of hyperhomocysteinemia. The product functions by providing essential vitamin B12 for metabolic pathways necessary for red blood cell production, nerve function, and DNA synthesis. It is approved and available in Brazil as a dietary supplement.

Brand names
Mecobe
Other names
Mecobe vitamin B12mecobalaminamethylcobalamin
02

Targets

MMUT (Methylmalonyl-coenzyme A mutase)MTR (Methionine synthase)

Beyond the preview

Go deeper on Mecobe.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mecobe.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call